M. Wittkamp

Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.

P. Fisher, Anindita Das, Xiaoying Wang, 2005, Vascular pharmacology.

A comparison of pulmonary vein ostial anatomy by computerized tomography, echocardiography, and venography in patients with atrial fibrillation having radiofrequency catheter ablation.

K. Ellenbogen, J. V. Nixon, M. Wood, 2004, The American journal of cardiology.

Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.

F. Salloum, R. Kukreja, R. Ockaili, 2006, Journal of molecular and cellular cardiology.

Iron deficiency anemia and cardiac mortality in patients with left ventricular systolic dysfunction undergoing coronary stenting.

G. Vetrovec, A. Abbate, M. Cowley, 2010, Minerva cardioangiologica.

Safety of drug-eluting stents in patients with left ventricular dysfunction undergoing percutaneous coronary intervention.

G. Vetrovec, A. Abbate, M. Cowley, 2008, The American journal of cardiology.

Safety of drug-eluting stents in patients with left ventricular dysfunction undergoing percutaneous coronary intervention.

G. Vetrovec, A. Abbate, M. Cowley, 2008, The American journal of cardiology.